Converge Bio Inc.
One private offering reported to the SEC on Form D since 2016, $25.0M sold in all. Biotech, Delaware.
- Form D offerings: 1
- Reported sold: $25.0M
- Newest: Apr 28, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Filed | Round | Sold | Offering | Filed as | Last amended | Filing |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | โ | $25.0M | $25.0M | Converge Bio Inc.Biotech ยท Delaware | Not amended | 0002131104-26-000001 |
- Business address
- Claymont, De
- Incorporated in
- Delaware
- All SEC filings
- CIK 2131104 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR